Literature DB >> 19924134

Keratinocytes synthesize enteropeptidase and multiple forms of trypsinogen during terminal differentiation.

Jotaro Nakanishi1, Mami Yamamoto, Junichi Koyama, Junko Sato, Toshihiko Hibino.   

Abstract

Members of the trypsin-like and chymotrypsin-like kallikrein family are important in the desquamation process. In this study, we isolated cDNA clones encoding trypsinogen 4 (brain trypsinogen) and a previously unreported isoform of trypsinogen from a human keratinocyte cDNA library. The nucleotide sequence of the new isoform only differs from those of trypsinogen 3 (mesotrypsinogen) and trypsinogen 4 in an exon encoding the N-terminal region, indicating that this isoform is an alternative splicing variant of the mesotrypsinogen gene PRSS3. Both isoforms contained the sequence DDDDK-I, a putative cleavage site for activation by enteropeptidase. Thus, after activation, mesotrypsin would be produced. Immunohistochemical and in situ hybridization studies revealed that trypsinogens were expressed and localized in the upper epidermis, especially in the granular layer. In cultured keratinocytes, enteropeptidase mRNA was expressed at the confluent stage, and its expression was strongly upregulated after air exposure. Interestingly, it was synthesized and localized only at the granular layer, suggesting that the generation of active mesotrypsin is restricted to this layer. The enteropeptidase-cleavage product was also found at the same layer. When a skin equivalent model was cultured in the medium without air exposure, the cornified layer was not formed, and many cells expressed trypsinogens and enteropeptidase. Those cells were found to be TUNEL positive. Because mesotrypsin is resistant to naturally occurring trypsin inhibitors, confined expression of the isoforms of mesotrypsinogens and enteropeptidase may indicate that mesotrypsin is involved in keratinocyte terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19924134     DOI: 10.1038/jid.2009.364

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

Review 1.  Biochemical and structural insights into mesotrypsin: an unusual human trypsin.

Authors:  Moh'd A Salameh; Evette S Radisky
Journal:  Int J Biochem Mol Biol       Date:  2013-09-13

2.  The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

3.  Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.

Authors:  Bonan Lin; Xiaomeng Zhou; Shuye Lin; Xiaoyue Wang; Meiying Zhang; Baoping Cao; Yan Dong; Shuai Yang; Ji Ming Wang; Mingzhou Guo; Jiaqiang Huang
Journal:  J Mol Med (Berl)       Date:  2017-08-26       Impact factor: 4.599

4.  Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form.

Authors:  Mami Yamamoto; Masashi Miyai; Yuuko Matsumoto; Ryoji Tsuboi; Toshihiko Hibino
Journal:  J Biol Chem       Date:  2012-07-23       Impact factor: 5.157

5.  Determinants of affinity and proteolytic stability in interactions of Kunitz family protease inhibitors with mesotrypsin.

Authors:  Moh'd A Salameh; Alexei S Soares; Duraiswamy Navaneetham; Dipali Sinha; Peter N Walsh; Evette S Radisky
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

6.  Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.

Authors:  Masashi Miyai; Yuuko Matsumoto; Haruyo Yamanishi; Mami Yamamoto-Tanaka; Ryoji Tsuboi; Toshihiko Hibino
Journal:  J Invest Dermatol       Date:  2014-01-03       Impact factor: 8.551

7.  Characterization of dsRNA-induced pancreatitis model reveals the regulatory role of IFN regulatory factor 2 (Irf2) in trypsinogen5 gene transcription.

Authors:  Hideki Hayashi; Tomoko Kohno; Kiyoshi Yasui; Hiroyuki Murota; Tohru Kimura; Gordon S Duncan; Tomoki Nakashima; Kazuo Yamamoto; Ichiro Katayama; Yuhua Ma; Koon Jiew Chua; Takashi Suematsu; Isao Shimokawa; Shizuo Akira; Yoshinao Kubo; Tak Wah Mak; Toshifumi Matsuyama
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

8.  PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.

Authors:  Alexandra Hockla; Erin Miller; Moh'd A Salameh; John A Copland; Derek C Radisky; Evette S Radisky
Journal:  Mol Cancer Res       Date:  2012-12       Impact factor: 5.852

9.  In vitro amyloidogenic peptides of galectin-7: possible mechanism of amyloidogenesis of primary localized cutaneous amyloidosis.

Authors:  Koji Ono; Eita Fujimoto; Norihiro Fujimoto; Minoru Akiyama; Takahiro Satoh; Hiroki Maeda; Noriko Fujii; Shingo Tajima
Journal:  J Biol Chem       Date:  2014-08-29       Impact factor: 5.157

10.  Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation.

Authors:  Mami Yamamoto-Tanaka; Akira Motoyama; Masashi Miyai; Yukiko Matsunaga; Junko Matsuda; Ryoji Tsuboi; Toshihiko Hibino
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.